ContractPatent Licensing Agreement • November 19th, 2020
Contract Type FiledNovember 19th, 2020Optional contractual provision: (provisions marked as "contractual provision" can be kept at user´s option or omitted without replacement) [____] alternative clauses and comments of industrial partners / research institutiones [____] options, alternatives to be chosen directly within the agreement ___________ (to be completed by the user) (____) assistance for fill in areas, options, alternatives PATENT LICENSING AGREEMENT concluded between _____________(university, research institute) represented by ___________(name) __________________(address) (hereinafter referred to as “Licensor”) as the party of the first part and __________________(name, company) a company established under _______________(e.g. Austrian) law ______________(commercial register number), __________________(competent court) having its registered office in __________(place) ___________________(address) (hereinafter referred to as “Licensee”) as the party of the second part (together hereina
EXHIBIT 10.2Patent Licensing Agreement • July 21st, 1998 • Imaging Diagnostic Systems Inc /Fl/ • Electromedical & electrotherapeutic apparatus
Contract Type FiledJuly 21st, 1998 Company Industry
CONTRACT NUMBER:Patent Licensing Agreement • December 30th, 2016
Contract Type FiledDecember 30th, 2016This ‘multi-talker’ separation greatly enhances communication effectiveness and serves to improve safety during flight operations, according to Dr. Brian Simpson, technical advisor for the 711 HPW/RH Battlespace Acoustics Branch, which developed the technology.
ARTICLE I THE GRANTPatent Licensing Agreement • March 15th, 2005 • Americhip International Inc • Special industry machinery (no metalworking machinery) • Michigan
Contract Type FiledMarch 15th, 2005 Company Industry Jurisdiction
PLAPatent Licensing Agreement • May 29th, 2020
Contract Type FiledMay 29th, 2020This PATENT LICENSING AGREEMENT (the “PLA”) is entered into by and between SmartHealth PayCard, LLC (“SHPC”), and the party set forth on the signature page to the Agreement, as defined below (the “Company”), effective as of the date set forth on the signature page (the “PLA Effective Date”). This PLA is subject to and incorporates the terms and conditions of the MASTER MARKETING AGREEMENT by and between SHPC and the Company dated effective as of
Page 93 TITLE 35—PATENTS § 207Patent Licensing Agreement • September 24th, 2024
Contract Type FiledSeptember 24th, 2024sell any subject invention in the United States unless such person agrees that any products em- bodying the subject invention or produced through the use of the subject invention will be manufactured substantially in the United States. However, in individual cases, the re- quirement for such an agreement may be waived by the Federal agency under whose funding agreement the invention was made upon a show- ing by the small business firm, nonprofit organi- zation, or assignee that reasonable but unsuc- cessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the United States or that under the cir- cumstances domestic manufacture is not com- mercially feasible.
SCHEDULE A AMENDMENT NO. 4 TO PATENT LICENSING AGREEMENT NO. C-00061906Patent Licensing Agreement • March 12th, 2015 • Cellectis S.A. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 12th, 2015 Company IndustryOn June 19, 2000, the Parties signed the license agreement no. C-00061906 (hereafter the “AGREEMENT”), by which the LICENSOR grants the LICENSEE exploitation rights to the above mentioned patents and patent applications.
ContractPatent Licensing Agreement • March 2nd, 2017
Contract Type FiledMarch 2nd, 2017Japan Material Technologies Corporation and Mitsui Chemicals Sign a Patent Licensing Agreement for Water- Soluble Polyurethane
Patent Licensing AgreementPatent Licensing Agreement • March 14th, 2018 • HUYA Inc. • Services-computer programming, data processing, etc.
Contract Type FiledMarch 14th, 2018 Company IndustryAddress: Building B-1, North District, Wanda Plaza, Wanbo Business District, 79 Wanbo Second Road, Nancun Town, Panyu District, Guangzhou;
Q&A ON THREE RIVERS RIBAVIRIN PATENT AGREEMENTPatent Licensing Agreement • February 7th, 2003 • Schering Plough Corp • Pharmaceutical preparations
Contract Type FiledFebruary 7th, 2003 Company Industry
PATENT LICENSING AGREEMENT BETWEEN MANTHEY REDMOND CORPORATION AND MANTHEY REDMOND (AUST) PTY LIMITEDPatent Licensing Agreement • November 10th, 2009 • MANTHEY REDMOND Corp • Engines & turbines • Queensland
Contract Type FiledNovember 10th, 2009 Company Industry Jurisdiction
ContractPatent Licensing Agreement • June 16th, 2021
Contract Type FiledJune 16th, 2021
AMENDED AND RESTATED PATENT LICENSING AGREEMENTPatent Licensing Agreement • June 10th, 2005 • Neomagic Corp • Semiconductors & related devices • Delaware
Contract Type FiledJune 10th, 2005 Company Industry JurisdictionThis AMENDED AND RESTATED PATENT LICENSING AGREEMENT (hereinafter referred to as the “Agreement”) is made and entered into March 28, 2005 (the “Effective Date”) by and between NeoMagic Corporation, a corporation duly organized and existing under the laws of the State of Delaware and having its principal office at 3250 Jay Street, Santa Clara, California, 95054 (hereinafter referred to as “NEOMAGIC”) and The Consortium for Technology Licensing, Ltd., a corporation duly organized under the laws of the State of New York and having its principal office at Six Swan Place, Nissequogue, New York 11780-1335 (hereinafter referred to as “CONSORTIUM”). This Agreement amends and restates in its entirety the April 1, 2002 Patent Licensing Agreement and all amendments thereto between NEOMAGIC and CONSORTIUM.
CONTRACT NUMBER:Patent Licensing Agreement • June 20th, 2018
Contract Type FiledJune 20th, 2018
SCHEDULE A AMENDMENT NO. 4 TO PATENT LICENSING AGREEMENT NO. C-00061906Patent Licensing Agreement • March 12th, 2019 • Cellectis S.A. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 12th, 2019 Company IndustryOn June 19, 2000, the Parties signed the license agreement no. C-00061906 (hereafter the “AGREEMENT”), by which the LICENSOR grants the LICENSEE exploitation rights to the above mentioned patents and patent applications.
PATENT & LICENSING RIGHTS AGREEMENTPatent Licensing Agreement • April 29th, 2014 • RX Safes, Inc. • Miscellaneous fabricated metal products • New York
Contract Type FiledApril 29th, 2014 Company Industry JurisdictionThis Agreement is a Patent Licensing rights agreement between bioMETRX, Inc., (bioMETRX) and Axius Consulting Group, Inc. (Licensee).
Ancillary agreements to a JV contractPatent Licensing Agreement • October 14th, 2019
Contract Type FiledOctober 14th, 2019Between FOREIGN whose principal office is [address] represented by [name and position], which is hereinafter called "the Licensor"
Portable Chemical SterilizerPatent Licensing Agreement • April 18th, 2017
Contract Type FiledApril 18th, 2017
Discover Financial Services and USAA Sign RDC Patent Licensing AgreementPatent Licensing Agreement • August 30th, 2023
Contract Type FiledAugust 30th, 2023With multiple RDC license agreements in place, Banks have begun to acknowledge USAA’s patent rights. “We look forward to working with more banks to create reasonable licensing agreements that benefit their customers,” McKinley added.
An offer for Patent LicensingPatent Licensing Agreement • June 23rd, 2022
Contract Type FiledJune 23rd, 2022In some applications, optical characterization may need a narrowband light source, while in others may need broadband illumination with a specific spectral distribution, and thus a plurality of pieces of equipment for a full characterization. For example, solar cell power conversion efficiency is characterized using a solar simulator with a broadband spectrum adjusted to outdoor sunlight or others, but external quantum efficiency is measured using monochromatic wavelength illumination.
SPANISH NATIONAL RESEARCH COUNCIL (CSIC)Patent Licensing Agreement • February 20th, 2019
Contract Type FiledFebruary 20th, 2019CSIC and the University Miguel Hernández have developed a minimal peptide core from the Mytilus galloprovidencialis Myticin C peptide with unique in vitro and in vivo wound healing and regenerating activities.
Patent Licensing AgreementPatent Licensing Agreement • July 7th, 2010 • Emerald Acquisition CORP • Canned, frozen & preservd fruit, veg & food specialties
Contract Type FiledJuly 7th, 2010 Company IndustryOn May 25, 2009, Party A filed the below application to the State Intellectual Property Office of the People’s Republic of China (“SIPO”):